‘Reade’ all about it: Duane Reade introduces new publication
NEW YORK Duane Reade is introducing hundreds of new and exclusive products in time for the holidays with a new publication called “The Duane Reader.”
Joe Jackman, acting chief marketing officer, said, “‘The Duane Reader’ represents our most recent effort to strengthen our brand image in order to match the positive changes that we are making to our customer experience. It’s our hope that busy New Yorkers will find it to be a relevant, useful and entertaining companion for city living during the holidays.”
“The Duane Reader” spotlights hundreds of products at hot introductory prices that will be in effect through Jan. 1, 2010. It also profiles new and New York-centric items. Many of the products highlighted make their debut under one of the exclusive Duane Reade private-label brands, including DR Delish, Apt 5 and beauty brand Look NY.
“Virtually all the products in ‘The Duane Reader’ have a connection to city living, with many created especially for the joyous holiday season,” said Joe Magnacca, chief merchandising officer. “We are thrilled to use this unique publication to highlight the great values and wonderful array of new and exciting products that our team has been busy creating. Whether stocking-stuffer gifts, easy entertaining or quality food choices on the run, we had fun tying in these items to the everyday events and happenings that we experience as we get ready for the holidays in New York.”
FDA approves rare skin cancer treatment
ROCKVILLE, Md. The Food and Drug Administration has approved a new drug for treating a skin cancer that affects fewer than 20,000 people in the United States.
Gloucester Pharmaceuticals announced the FDA’s approval of Istodax (romidepsin) for the treatment of cutaneous T-cell lymphoma, a type of non-Hodgkin’s lymphoma also known as CTCL, in patients who have received at least one prior systemic therapy. The cancer affects between 16,000 and 20,000 people in the United States and is most common among men ages 50 years and older, according to the Cutaneous Lymphoma Foundation.
“CTCL is a devastating cancer in which many patients suffer from disfiguring tumors, horribly itchy and infected skin and, in advanced stages, lesions in other organs,” Stanford Cancer Center professor and Istodax clinical trial investigator Youn Kim stated. “Current systemic therapies have proved inadequate, and patients with CTCL desperately need treatment options that can offer sustained relief from their disease so they can live fuller lives.”
Price Chopper opens new Mass.-based store
SCHENECTADY, N.Y. Northeastern supermarket chain Price Chopper has opened a new store in Shrewsbury, Mass., the company said.
The 64,000-sq.-ft. store incorporates numerous environmentally friendly features and was designed to win silver-level certification in the U.S. Green Building Council’s Leadership in Energy and Environmental Design program. Features include skylights, freezers and cases lit with LED lightbulbs and a composting system for unused, produce, meat, seafood and deli products.
“We are so pleased to offer a brand new, state-of-the-art supermarket here in Shrewsbury that contains many of our signature products and services,” Price Chopper CEO and chairman Neil Golub said. “We look forward to providing Price Chopper quality, value and customer service to all those who enter our doors and relish the opportunity to continue supporting local projects and events that nourish the community around us.”
The store also includes a full-service pharmacy offering the chain’s 30-day and 90-day generic discount programs and the Diabetes AdvantEdge disease management program.